InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.670
+0.030 (1.83%)
At close: Jul 28, 2026, 4:00 PM EDT
1.600
-0.070 (-4.19%)
After-hours: Jul 28, 2026, 7:59 PM EDT
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $7.46 million as of July 28, 2026. Its market cap has increased by 133.94% in one year.
Market Cap
7.46M
Enterprise Value
2.74M
1-Year Change
133.94%
Ranking
Category
Stock Price
$1.67
ChartMarket Cap Chart
Since May 6, 2014, InMed Pharmaceuticals's market cap has decreased from $9.40M to $7.46M, a decrease of -20.68%. That is a compound annual growth rate of -1.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 7.46M | 77.86% |
| Dec 31, 2025 | 4.19M | 22.12% |
| Dec 31, 2024 | 3.43M | 57.02% |
| Dec 29, 2023 | 2.19M | -31.94% |
| Dec 30, 2022 | 3.21M | -82.66% |
| Dec 31, 2021 | 18.52M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aytu BioPharma | 23.18M |
| Biofrontera | 13.96M |
| Caring Brands | 13.18M |
| Apimeds Pharmaceuticals US | 8.53M |
| Gelteq | 7.84M |
| Akanda | 6.07M |
| cbdMD | 5.65M |
| Sonoma Pharmaceuticals | 5.46M |